[1] Adhoute X, Penaranda G, Blanc J, et al. P0376: Stratification of hepatocellular carcinoma. The prognostic score NIACE, an additional aid to the Barcelona Clinic Liver Cancer (BCLC) staging system? Multicenter study. J Hepatol, 2015, 62:S453.
[2] Peserico G, Penzo B, Pelizzaro F, et al. Monofocal hepatocellular carcinoma (HCC): Is diameter so important? Analysis on the Italian Liver Cancer (ITA. LI. CA) database between BCLC algorithm and Milan criteria. Dig Liver Dis, 2018, 50:53.
[3] Ciria R, López-Cillero P, Gallardo AB, et al. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization. Eur J Surg Oncol, 2015, 41:1153-1161.
[4] Adhoute X, Pénaranda G, Sellier F, et al. Response to ‘the flexible therapeutic approach to the BCLC B stage’: Time for scoring systems?. J Hepatol, 2018, 68:214-215.
[5] Kudo M, Arizumi T, Ueshima K, et al. Subclassification of BCLC B stage hepatocellular carcinoma and treatment strategies: proposal of modified Bolondi's subclassification (Kinki criteria). Dig Dis, 2015, 33:751-758.
[6] Yin X, Zhang L, Wang YH, et al. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.BMC cancer, 2014, 14:849.
[7] Farinati F, Vanin V, Giacomin A, et al. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoem-bolization: a 20-year survey by the Italian Liver Cancer group.Liver Int, 2015, 35:223-231.
[8] 朱倩, 乔国梁, 晏建军, 等.巴塞罗那分期 A 期及 B 期肝细胞癌自发破裂的危险因素及预后.中华肝胆外科杂志, 2015,21: 81-85.
[9] 钟鉴宏, 柯阳, 王言焱, 等.巴塞罗那中晚期肝细胞癌肝切除术和经肝动脉化疗栓塞术的疗效分析.中国癌症防治杂志, 2014, 6: 363-370. |
